Community pharmacist identification of chronic kidney disease using point-of-care technology: A pilot study

Glassock RJ Warnock DG Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol 2017;13(2):104-14.

Arora P Vasa P Brenner D , et al. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 2013;185(9):E417-23.

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Working Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013;3(1):1-150.

Zillich AJ Saseen JJ Dehart RM , et al. Caring for patients with chronic kidney disease: a joint opinion of the ambulatory care and the nephrology practice and research networks of the American College of Clinical Pharmacy. Pharmacotherapy 2005;25(1):123-43.

Curtis C Balint C Al Hamarneh YN , et al. Online clinical pathway for managing adults with chronic kidney disease. Can Pharm J (Ott) 2015;148(5):257-62.

Al Hamarneh YN Hemmelgarn B Curtis C , et al. Community pharmacist targeted screening for chronic kidney disease. Can Pharm J (Ott) 2016;149(1):13-7.

Alberta Health Services. Framework for implementation of expanded scope of practice for pharmacists. Alberta: Alberta Health Services; 2013.

Donovan JN Tsuyuki RT Al Hamarneh YN Bajorek B. Barriers to a full scope of pharmacy practice in primary care: A systematic review of pharmacists’ access to laboratory testing. Can Pharm J (Ott) 2019;152:317-33.

Haneder S Gutfleisch A Meier C , et al. Evaluation of a handheld creatinine measurement device for real-time determination of serum creatinine in radiology departments. World J Radiol 2012;4(7):328-34.

Korpi-Steiner NL Williamson EE Karon BS. Comparison of three whole blood creatinine methods for estimation of glomerular filtration rate before radiographic contrast administration. Am J Clin Pathol 2009;132(6):920-6.

Shephard M Peake M Corso O , et al. Assessment of the Nova StatSensor whole blood point-of-care creatinine analyzer for the measurement of kidney function in screening for chronic kidney disease. Clin Chem Lab Med 2010;48(8):1113-9.

Srihong C Pangsapa K Chuaboonmee K , et al. Evaluation of the analytical performance of the nova StatSensor creatinine meter for blood testing. J Med Assoc Thai 2012;95(9):1225-31.

Morita S Suzuki K Masukawa A , et al. Assessing renal function with a rapid, handy, point-of-care whole blood creatinine meter before using contrast materials. Jpn J Radiol 2011;29(3):187-93.

Schnabl KL Bagherpoor S Diker P , et al. Evaluation of the analytical performance of the Nova StatSensor creatinine meter and reagent strip technology for whole blood testing. Clin Biochem 2010;43(12):1026-9.

Jafar TH Schmid CH Landa M , et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data. Ann Intern Med 2001;135(2):73-87.

Lewis EJ Hunsicker LG Clarke WR , et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345(12):851-60.

Wright JT Jr Bakris G Greene T , et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002;288(19):2421-31.